Covid-19
Why natural immunity better than COVID-19 vaccines, study reveals
Natural immunity appears to confer longer lasting and stronger protection against SARS-CoV-2 infection, symptomatic disease and hospitalization from the Delta variant compared to Pfizer-BioNTech’s two-dose vaccine-induced immunity, according to a new Israeli preprint study.
The study, published Aug. 25 on medRxiv, was conducted in one of the most highly vaccinated countries in the world using data from Maccabi Healthcare Services, which enrolls about 2.5 million Israelis, or about 26% of the population.
Researchers examined medical records of 673,676 Israelis 16 years and older — charting their infections, symptoms and hospitalizations between June 1 and Aug. 14, when the Delta variant predominated in Israel.
“This analysis demonstrated that natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalization due to the Delta variant,” the researchers said.
READ ALSO: Woman dies after Pfizer COVID-19 vaccination
“It’s a textbook example of how natural immunity is really better than vaccination,” Charlotte Thålin, a physician and immunology researcher at Danderyd Hospital and the Karolinska Institute, told Science. “To my knowledge, it’s the first time [this] has really been shown in the context of COVID-19.”
In one analysis that assessed more than 32,000 people in the health system, the risk of developing symptomatic COVID was 27 times higher among the vaccinated and the risk of hospitalization eight times higher, Science reported.
A closer look at the data reveals public-health communication may be overstating the vaccine’s effect on transmission and understating the scale and risk of breakthrough infections, the Intelligencer reported.
READ ALSO: Reported cases of COVID-19 vaccines’ fatalities rise
“The message that breakthrough cases are exceedingly rare and that you don’t have to worry about them if you’re vaccinated — that this is only an epidemic of the unvaccinated — that message is falling flat,” said Dr. Michael Mina, a Harvard epidemiologist.
“If this was still Alpha, sure. But with Delta, plenty of people are getting sick,” said Mina. “Plenty of transmission is going on. And my personal opinion is that the whole notion of herd immunity from two vaccine shots is flying out the window very quickly with this new variant.”
According to the most recent data from the Centers for Disease Control and Prevention (CDC), as of Aug. 23, 11,050 fully vaccinated people with COVID breakthrough infection had been hospitalized or died.
-
Latest6 days agoCole-Alegbe unveils memoir, urges leaders to harness technology for lasting impact
-
Business3 days agoNigeria records N12.59trn trade surplus in Q2 2026 — NBS
-
Business4 days agoNigerian Breweries’ H1 profitability strengthens as revenue hits N804bn
-
Business6 days agoJetour G700 PHEV Storms Abuja as Jetour Nigeria Takes Luxury Mobility Showcase to FCT
-
Featured2 days agoPeter Obi, Makinde and the 2027 elections: Can unity really challenge APC?
-
Football2 days agoBanda, Chawinga make 2026 Women’s Ballon d’Or top 30 shortlist
-
Business1 week agoRising crude prices threaten fresh petrol price hike in Nigeria
-
Business7 days agoMultinationals exit Nigeria as economic pressures reshape business landscape


